tiprankstipranks
Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
India Market
JAGSNPHARM
Jagsonpal Pharmaceuticals Ltd.
RESEARCH TOOLSreports
Want to see IN:JAGSNPHARM full AI Analyst Report?

Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Ratios

2 Followers

Jagsonpal Pharmaceuticals Ltd. Ratios

IN:JAGSNPHARM's free cash flow for Q2 2026 was ₹0.63. For the 2026 fiscal year, IN:JAGSNPHARM's free cash flow was decreased by ₹ and operating cash flow was ₹0.23. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 5.06 5.06 6.22 10.42 5.97
Quick Ratio
 4.54 4.54 5.64 9.63 5.22
Cash Ratio
 0.35 0.35 4.97 0.67 0.40
Solvency Ratio
 1.30 1.30 1.66 0.81 0.77
Operating Cash Flow Ratio
 0.87 1.65 2.13 1.84 1.69
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 61.88
Net Current Asset Value
₹ 1.03B₹ 1.03B₹ 1.23B₹ 1.70B₹ 1.29B
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.03 0.04 0.03
Debt-to-Equity Ratio
 0.03 0.03 0.04 0.05 0.04
Debt-to-Capital Ratio
 0.03 0.03 0.04 0.05 0.04
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.15 1.15 1.16 1.16 1.23
Debt Service Coverage Ratio
 52.10 52.10 38.18 30.64 24.26
Interest Coverage Ratio
 47.31 47.31 45.46 26.29 83.18
Debt to Market Cap
 0.00 0.00 0.00 0.00 <0.01
Interest Debt Per Share
 1.31 1.37 1.51 1.47 0.98
Net Debt to EBITDA
 -0.03 -0.03 -2.34 -0.12 -0.14
Profitability Margins
Gross Profit Margin
63.66%63.66%64.11%31.27%60.67%
EBIT Margin
20.38%20.38%15.98%14.68%14.82%
EBITDA Margin
23.67%23.67%19.01%15.50%15.38%
Operating Profit Margin
16.93%16.93%16.21%10.26%14.50%
Pretax Profit Margin
20.03%20.03%26.00%14.31%14.70%
Net Profit Margin
15.00%15.00%20.60%10.76%11.29%
Continuous Operations Profit Margin
15.00%15.00%20.60%10.76%11.29%
Net Income Per EBT
74.90%74.90%79.25%75.21%76.77%
EBT Per EBIT
118.28%118.28%160.41%139.55%101.39%
Return on Assets (ROA)
13.60%13.60%19.90%10.35%13.71%
Return on Equity (ROE)
17.08%15.60%23.07%11.99%16.82%
Return on Capital Employed (ROCE)
16.86%16.86%17.26%10.81%20.51%
Return on Invested Capital (ROIC)
12.56%12.56%13.59%8.08%15.60%
Return on Tangible Assets
18.05%18.05%28.74%10.35%13.70%
Earnings Yield
2.97%3.45%3.79%2.98%3.52%
Efficiency Ratios
Receivables Turnover
 16.71 16.71 20.39 19.06 11.34
Payables Turnover
 9.01 9.01 9.91 14.74 11.86
Inventory Turnover
 7.13 7.13 6.34 9.56 4.50
Fixed Asset Turnover
 39.08 39.08 30.41 22.44 9.75
Asset Turnover
 0.91 0.91 0.97 0.96 1.21
Working Capital Turnover Ratio
 2.03 2.30 1.70 1.32 2.16
Cash Conversion Cycle
 32.55 32.55 38.58 32.54 82.46
Days of Sales Outstanding
 21.85 21.85 17.90 19.15 32.18
Days of Inventory Outstanding
 51.21 51.21 57.53 38.16 81.06
Days of Payables Outstanding
 40.50 40.50 36.84 24.77 30.79
Operating Cycle
 73.05 73.05 75.43 57.31 113.24
Cash Flow Ratios
Operating Cash Flow Per Share
 3.52 6.95 8.21 5.30 7.12
Free Cash Flow Per Share
 3.51 6.93 8.16 5.26 7.07
CapEx Per Share
 0.01 0.02 0.05 0.04 0.05
Free Cash Flow to Operating Cash Flow
 1.00 1.00 0.99 0.99 0.99
Dividend Paid and CapEx Coverage Ratio
 1.47 2.79 4.07 2.63 146.90
Capital Expenditure Coverage Ratio
 251.79 316.30 158.91 141.80 146.90
Operating Cash Flow Coverage Ratio
 3.02 5.73 5.99 3.93 7.77
Operating Cash Flow to Sales Ratio
 0.09 0.16 0.21 0.17 0.20
Free Cash Flow Yield
1.77%3.73%3.76%4.64%6.10%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 33.69 29.01 26.40 33.53 28.41
Price-to-Sales (P/S) Ratio
 4.84 4.35 5.44 3.61 3.21
Price-to-Book (P/B) Ratio
 5.26 4.53 6.09 4.02 4.78
Price-to-Free Cash Flow (P/FCF) Ratio
 56.56 26.78 26.60 21.57 16.38
Price-to-Operating Cash Flow Ratio
 58.82 26.70 26.43 21.42 16.27
Price-to-Earnings Growth (PEG) Ratio
 -1.50 -1.29 0.18 -2.01 0.68
Price-to-Fair Value
 5.26 4.53 6.09 4.02 4.78
Enterprise Value Multiple
 20.42 18.35 26.28 23.17 20.72
Enterprise Value
 13.88B 12.48B 13.42B 7.49B 7.54B
EV to EBITDA
 20.42 18.35 26.28 23.17 20.72
EV to Sales
 4.83 4.34 5.00 3.59 3.19
EV to Free Cash Flow
 56.49 26.74 24.43 21.46 16.28
EV to Operating Cash Flow
 56.26 26.66 24.27 21.31 16.17
Tangible Book Value Per Share
 28.28 29.45 22.92 28.23 24.26
Shareholders’ Equity Per Share
 39.40 41.03 35.63 28.23 24.26
Tax and Other Ratios
Effective Tax Rate
 0.25 0.25 0.21 0.25 0.23
Revenue Per Share
 40.98 42.67 39.90 31.44 36.14
Net Income Per Share
 6.15 6.40 8.22 3.38 4.08
Tax Burden
 0.75 0.75 0.79 0.75 0.77
Interest Burden
 0.98 0.98 1.63 0.97 0.99
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.26 0.02 0.02
Stock-Based Compensation to Revenue
 0.02 <0.01 0.03 0.06 0.04
Income Quality
 0.34 0.81 1.00 1.57 1.34
Currency in INR